Synthaverse's earnings have been declining at an average annual rate of -46.6%, while the Biotechs industry saw earnings growing at 17% annually. Revenues have been growing at an average rate of 7.4% per year.
Key information
-46.63%
Earnings growth rate
-46.10%
EPS growth rate
Biotechs Industry Growth
-14.59%
Revenue growth rate
7.36%
Return on equity
-18.97%
Net Margin
-54.52%
Next Earnings Update
30 Sep 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Synthaverse makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
DB:6NQ Revenue, expenses and earnings (PLN Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
42
-23
39
0
31 Dec 25
42
-20
37
0
30 Sep 25
54
-6
36
0
30 Jun 25
62
1
36
0
31 Mar 25
71
7
34
0
31 Dec 24
72
8
32
0
30 Sep 24
63
4
29
0
30 Jun 24
57
2
28
0
31 Mar 24
61
4
27
0
31 Dec 23
59
5
25
0
30 Sep 23
53
3
22
0
30 Jun 23
58
7
20
0
31 Mar 23
54
7
18
0
31 Dec 22
50
6
17
0
30 Sep 22
51
7
17
0
30 Jun 22
44
4
16
0
31 Mar 22
44
5
15
0
31 Dec 21
41
4
15
0
30 Sep 21
39
5
15
0
30 Jun 21
40
5
15
0
31 Mar 21
35
2
16
0
31 Dec 20
40
4
16
0
30 Sep 20
41
2
15
0
30 Jun 20
40
3
15
0
31 Mar 20
40
3
15
0
31 Dec 19
39
2
15
0
30 Sep 19
35
-29
16
0
30 Jun 19
36
-31
17
0
31 Mar 19
35
-32
17
0
31 Dec 18
32
-32
16
0
30 Sep 18
31
10
15
0
30 Jun 18
31
11
16
0
31 Mar 18
30
1
17
0
31 Dec 17
31
1
18
0
30 Sep 17
31
-23
18
0
30 Jun 17
32
-27
20
0
31 Mar 17
37
-26
20
0
31 Dec 16
36
-26
20
0
30 Sep 16
46
-48
21
0
30 Jun 16
45
-45
18
0
31 Mar 16
47
-35
18
0
31 Dec 15
43
-37
17
0
30 Sep 15
38
-2
14
0
30 Jun 15
36
-2
13
0
Quality Earnings: 6NQ is currently unprofitable.
Growing Profit Margin: 6NQ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6NQ is unprofitable, and losses have increased over the past 5 years at a rate of 46.6% per year.
Accelerating Growth: Unable to compare 6NQ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6NQ is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (7.2%).
Return on Equity
High ROE: 6NQ has a negative Return on Equity (-18.97%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/11 11:25
End of Day Share Price
2026/06/11 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Synthaverse S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.